A Cyclized Bivalent Aptamer-Based Protein Degrader Targeting Receptor Tyrosine Kinases Overcomes Resistance to Inhibitors in Lung Cancer
Shanchao Wu(Hunan University), Weihong Tan(Petronas (Malaysia)), Zilong Zhao(The University of Texas MD Anderson Cancer Center), Yanxue Shang(Hunan University), Yuping Yan(Hunan University), Xinyi Zhou(Wuhan University), Lili Ai(Hunan University)
Cited by 7
Related Papers
Conjugation of Biomolecules with Luminophore-Doped Silica Nanoparticles for Photostable Biomarkers
|Analytical Chemistry|2001|748
Nanotechnology in Therapeutics: A Focus on Nanoparticles as A Drug Delivery System
|Nanomedicine|2012|609
Preparation and antibacterial activity of Fe<sub>3</sub>O<sub>4</sub>@Ag nanoparticles
|Nanotechnology|2007|600
Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation
|Nature Communications|2016|597
Activatable Fluorescence/MRI Bimodal Platform for Tumor Cell Imaging via MnO<sub>2</sub> Nanosheet–Aptamer Nanoprobe
|Journal of the American Chemical Society|2014|585